Recombinant DNA Technology Market Report 2023

Recombinant DNA Technology Global Market Report 2024 – By Product Type( Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing ), By Component Type( Expression System, Cloning Vector), By Application Type( Food And Agriculture, Health And Disease, Environment, Other Application Types), By End-Use Type( Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Recombinant DNA Technology Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Recombinant DNA Technology Market Definition And Segments

Recombinant DNA technology refers to fusing DNA molecules from other organisms and inserting those DNA molecules into a host organism to build a new genetic combinations useful for science, medicine, agriculture, and industry. The recombinant DNA technology is used to address health issues by creating new medications and vaccines.

The main product type of recombinant DNA technology includes recombinant protein drugs, vaccines, genetically modified crops, expression systems, cell and gene therapy and gene editing. The recombinant protein drugs are used in the biochemical analysis as well as medical diagnostic reagents in human healthcare, such as antibodies, medicines, or vaccines. Recombinant protein drugs are referred to as highly potent medicines that develop faster than small molecules and are safe from off-target negative effects. The component type includes expression system and cloning vector. The recombinant DNA technology is applied in food and agriculture, health and disease, environment and other applications and used in biotechnology and pharmaceutical companies, academic and government research institutes and other end-use industries.

The recombinant DNA technology market covered in this report is segmented –

1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing

2) By Component Type: Expression System, Cloning Vector

3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types

4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types

The recombinant DNA technology market size has grown strongly in recent years. It will grow from $816.9 billion in 2023 to $882.04 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to healthcare demands, biopharmaceutical industry growth, rising investments in R&D, emergence of personalized medicine.

The recombinant DNA technology market size is expected to see strong growth in the next few years. It will grow to $1,214.85 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising chronic diseases, emerging biotech startups, increasing funding in biotech, globalization of biotech markets, consumer acceptance and education. Major trends in the forecast period include scientific advancements, gene editing advancements, cell and gene therapies, development of RNA therapeutics, therapeutic applications in rare diseases, AI and data integration.

Rising Prevalence Of Chronic Diseases To Drive Market Growth

The increasing number of chronic diseases is expected to propel the growth of the recombinant DNA technology market. Chronic diseases, which are defined as ailments that last for a year or longer, necessitate continuing medical care, restrict everyday activities, or both. Recombinant DNA technology has improved healthcare by creating biopharmaceuticals proteins used in pharmaceuticals and by replacing defective genes with healthy ones through gene therapy, aiming to cure illness. For instance, in April 2021, according to a report shared by WHO, a Switzerland-based specialized agency of the United Nations responsible for international public health, noncommunicable diseases (NCDs) accounted for 41 million annual deaths, or 71% of all deaths worldwide. Between the ages of 30 and 69, more than 15 million people per year die from an NCD; 85% of these premature deaths take place in low- and middle-income nations. Therefore, the increase in chronic diseases is driving the growth of the recombinant DNA technology market.

Rising Development Of Genetically Modified Crops To Drive Market Growth

The increasing development of genetically modified crops is expected to propel the growth of recombinant DNA technology market going forward. Genetically modified crops refer to plants whose genetic makeup has been intentionally altered using biotechnological techniques. Recombinant DNA (rDNA) technology is employed in genetically modified (GM) crops by isolating genes that confer desired traits, constructing recombinant DNA, introducing it into host crop cells, selecting and screening for successful integration, regenerating transgenic plants, testing for trait expression, conducting field trials, obtaining regulatory approval, and ultimately commercializing crops with improved characteristics. For instance, in October 2023, according to United States Department of Agriculture, a US-based government agency, in 2021, herbicide-tolerant (HT) soybean acreage increased to 95 percent, and this percentage remained unchanged in 2023. Additionally, in 2023, 91 percent of domestic corn acres were planted with HT seeds, and 89 percent of U.S. cotton acres utilized genetically engineered, insect-resistant seeds. Therefore, the increasing development of genetically modified crops is driving the growth of recombinant DNA technology market.

Major companies operating in the recombinant DNA technology market report are Profacgen BioTech Corp., Amgen Inc., Novartis International AG, GenScript Biotech Corporation, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co. Inc., Biogen Inc., GlaxoSmithKline PLC, New England Biolabs Inc., Bayer CropScience, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., Gilead Sciences Inc., Moderna Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics AG, Editas Medicine Inc., bluebird bio Inc., Illumina Inc., Qiagen N.V., Lonza Group AG, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Becton Dickinson and Company, Sartorius AG, Abcam PLC, Horizon Discovery Group PLC, Integrated DNA Technologies Inc., Twist Bioscience Corporation, Synthego Corporation, Codex DNA Inc., InvivoGen, Eurofins Scientific SE, Sarepta Therapeutics Inc., Sangamo Therapeutics Inc.

Technological Advancements Driving Innovation In Recombinant DNA Technology Market

Technological advancement is a key trend in the recombinant DNA technology market. Major companies operating in the recombinant DNA technology market are focused on innovative technologies to sustain their position in the market. For instance, in October 2021, Thermo Fisher Scientific, a US-based supplier of scientific instrumentation, reagents and consumables, and software services, introduced the Applied Biosystem QuantStudio Absolute Q-Digital PCR System, the first fully integrated digital PCR (dPCR) equipment made to deliver extremely precise and reliable findings in genetic analysis and research in less than 90 minutes. The QuantStudio Absolute Q System uses microfluidic array technology and streamlined processes instead of the complicated, multi-instrument workflows necessary for standard dPCR, which is intended to increase data accuracy and consistency. The QuantStudio Absolute Q solution is a quick and easy workflow that provides high-quality data with the least amount of manual labor. It combines the data collection, heat cycling, and digitization processes required for dPCR into a single device.

Product Innovations Transforming The Recombinant DNA Technology Market

Major companies operating in the recombinant DNA technology market are developing new vaccines to sustain their position in the market. For instance, in March 2022, Variation Biotechnologies Inc., a US-based biotechnology company launched PreHevbrio [Hepatitis B Vaccine (Recombinant)] in the United States. PreHevbrio received FDA approval in November 2021 and was subsequently added to the ACIP list of recommended adult HBV vaccines in February 2022. Administered as a 3-dose series via intramuscular injection on a 0-, 1-, and 6-month schedule, PreHevbrio contains the essential small (S), middle (pre-S2), and large (pre-S1) hepatitis B surface antigens, ensuring a robust immune response.

Thermo Fisher Acquires Peprotech, Boosting Recombinant Proteins And Bioscience Reagent Portfolio

In January 2022, Thermo Fisher Scientific, a US-based scientific instrumentation supplier, reagents, consumables, and software services, acquired PeproTech for $1.85 billion. The acquisition complements Thermo Fisher's cell culture media products with PeproTech's recombinant proteins portfolio, which is expected to allow Thermo Fisher to give customers significant advantages through an integrated offering. PeproTech Inc. is a US-based developer and manufacturer of bioscience reagents known as recombinant proteins.

North America was the largest region in the recombinant DNA technology market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant DNA technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the recombinant DNA technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The recombinant DNA technology market includes revenues earned by entities by expression systems including mammalian, bacteria, yeast, and baculovirus / insect. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The recombinant DNA technology market research report is one of a series of new reports from The Business Research Company that provides recombinant DNA technology market statistics, including recombinant DNA technology industry global market size, regional shares, competitors with an recombinant DNA technology market share, detailed recombinant DNA technology market segments, market trends and opportunities, and any further data you may need to thrive in the recombinant DNA technology industry. This recombinant DNA technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Recombinant DNA Technology Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $882.04 billion
Revenue Forecast In 2033 $1214.85 billion
Growth Rate CAGR of 8.3% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing
2) By Component Type: Expression System, Cloning Vector
3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types
4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Profacgen BioTech Corp.; Amgen Inc.; Novartis International AG; GenScript Biotech Corporation; Pfizer Inc.; Novo Nordisk A/S; Eli Lilly and Company; Sanofi S.A.; Merck & Co. Inc.; Biogen Inc.; GlaxoSmithKline PLC; New England Biolabs Inc.; Bayer CropScience; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd; Regeneron Pharmaceuticals Inc.; Gilead Sciences Inc.; Moderna Inc.; Vertex Pharmaceuticals Incorporated; CRISPR Therapeutics AG; Editas Medicine Inc.; bluebird bio Inc.; Illumina Inc.; Qiagen N.V.; Lonza Group AG; Bio-Rad Laboratories Inc.; Agilent Technologies Inc.; Becton Dickinson and Company; Sartorius AG; Abcam PLC; Horizon Discovery Group PLC; Integrated DNA Technologies Inc.; Twist Bioscience Corporation; Synthego Corporation; Codex DNA Inc.; InvivoGen; Eurofins Scientific SE; Sarepta Therapeutics Inc.; Sangamo Therapeutics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Recombinant DNA Technology Market Characteristics

    3. Recombinant DNA Technology Market Trends And Strategies

    4. Recombinant DNA Technology Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Recombinant DNA Technology Market Size and Growth

    5.1. Global Recombinant DNA Technology Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Recombinant DNA Technology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Recombinant DNA Technology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Recombinant DNA Technology Market Segmentation

    6.1. Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Recombinant Protein Drugs

    Vaccines

    Genetically Modified Crops

    Expression Systems

    Cell and Gene Therapy

    Gene Editing  

    6.2. Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Expression System

    Cloning Vector

    6.3. Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Food And Agriculture

    Health And Disease

    Environment

    Other Application Types

    6.4. Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Biotechnology And Pharmaceutical Companies

    Academic And Government Research Institutes

    Other End-Use Types

    7. Recombinant DNA Technology Market Regional And Country Analysis

    7.1. Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Recombinant DNA Technology Market  

    8.1. Asia-Pacific Recombinant DNA Technology Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Recombinant DNA Technology Market  

    9.1. China Recombinant DNA Technology Market Overview  

    9.2. China Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Recombinant DNA Technology Market  

    10.1. India Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Recombinant DNA Technology Market  

    11.1. Japan Recombinant DNA Technology Market Overview  

    11.2. Japan Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Recombinant DNA Technology Market  

    12.1. Australia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Recombinant DNA Technology Market  

    13.1. Indonesia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Recombinant DNA Technology Market  

    14.1. South Korea Recombinant DNA Technology Market Overview  

    14.2. South Korea Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Recombinant DNA Technology Market  

    15.1. Western Europe Recombinant DNA Technology Market Overview

    15.2. Western Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Recombinant DNA Technology Market  

    16.1. UK Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Recombinant DNA Technology Market  

    17.1. Germany Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Recombinant DNA Technology Market  

    18.5. France Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Recombinant DNA Technology Market  

    19.9. Italy Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Recombinant DNA Technology Market  

    20.13. Spain Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Recombinant DNA Technology Market  

    21.1. Eastern Europe Recombinant DNA Technology Market Overview

    21.2. Eastern Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Recombinant DNA Technology Market  

    22.1. Russia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Recombinant DNA Technology Market  

    23.1. North America Recombinant DNA Technology Market Overview

    23.2. North America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Recombinant DNA Technology Market  

    24.1. USA Recombinant DNA Technology Market Overview

    24.2. USA Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Recombinant DNA Technology Market  

    25.1. Canada Recombinant DNA Technology Market Overview

    25.2. Canada Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Recombinant DNA Technology Market  

    26.1. South America Recombinant DNA Technology Market Overview

    26.2. South America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Recombinant DNA Technology Market  

    27.1. Brazil Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Recombinant DNA Technology Market  

    28.1. Middle East Recombinant DNA Technology Market Overview

    28.2. Middle East Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Recombinant DNA Technology Market  

    29.1. Africa Recombinant DNA Technology Market Overview

    29.2. Africa Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Recombinant DNA Technology Market Competitive Landscape And Company Profiles

    30.1. Recombinant DNA Technology Market Competitive Landscape

    30.2. Recombinant DNA Technology Market Company Profiles

    30.2.1. Profacgen BioTech Corp.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Amgen Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Novartis International AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. GenScript Biotech Corporation

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Pfizer Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Recombinant DNA Technology Market Competitive Benchmarking

    32. Global Recombinant DNA Technology Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Recombinant DNA Technology Market

    34. Recombinant DNA Technology Market Future Outlook and Potential Analysis

    34.1 Recombinant DNA Technology Market In 2028 - Countries Offering Most New Opportunities

    34.2 Recombinant DNA Technology Market In 2028 - Segments Offering Most New Opportunities

    34.3 Recombinant DNA Technology Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Profacgen BioTech Corp. Financial Performance
  • Table 76: Amgen Inc. Financial Performance
  • Table 77: Novartis International AG Financial Performance
  • Table 78: GenScript Biotech Corporation Financial Performance
  • Table 79: Pfizer Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Profacgen BioTech Corp. Financial Performance
  • Figure 76: Amgen Inc. Financial Performance
  • Figure 77: Novartis International AG Financial Performance
  • Figure 78: GenScript Biotech Corporation Financial Performance
  • Figure 79: Pfizer Inc. Financial Performance
Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies
Read More
Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company
Read More
What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?
Read More
How Will The Laryngoscope Market Grow In 2022?
Read More
The Business Research Company offers the neuroscience antibodies and assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the narcotics scanner market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft doors market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft landing gear market research report 2022 with industry size, share, segments and market growth
Read More
Cell Therapy Global Market Report 2024 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell Culture Consumables And Equipment Global Market Report 2024 – By Product (Consumables, Instruments), By Application (Vaccination, Toxicity testing, Cancer Research, Drug Screening and Development, Recombinant Products, Stem cell technology, Regenerative Medicine, Other End Users), By End User (Industrial, Biotechnology, Agriculture, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell Based Assays Global Market Report 2024 – By Product & Service (Consumables, Instruments, Services, Software), By Technology (Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, Other Technologies), By Application (Drug Discovery, Basic Research, Adme Studies, Predictive Toxicology, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Contract Research Organizations (CRO), Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cellular Telephones Global Market Report 2024 – By Product Type (Smartphone, Feature Phone), By Age-Group (Under 18 Years Old, 18-45 Years Old, 45-60 Years Old, Above 60 Years Old), By Distribution channel (OEM, Retailer, E-commerce) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell Culture Global Market Report 2024 – By Type (Primary Cell Culture, Secondary Cell Culture, Cell Line), By Media (Natural, Artificial), By Applications (Stem Cell Technologies, Cancer Research, Biopharmaceutical, Tissue Engineering & Regenerative Medicine, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cellular Immunotherapy Global Market Report 2024 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell and Gene Therapy Global Market Report 2024 – By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cellular or Mobile Telephone Services Global Market Report 2024 – By Type (Basic Communication, Value-Added), By Service (3G Services, 4G Services, 5G Services), By End User (Manufacturing, Energy And Utilities, Media And Entertainment, It And Telecom, Transportation And Logistics, Healthcare) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the recombinant DNA technology market?

recombinant DNA technology refers to fusing DNA molecules from other organisms and inserting those DNA molecules into a host organism to build a new genetic combinations useful for science, medicine, agriculture, and industry. The recombinant DNA technology is used to address health issues by creating new medications and vaccines. For further insights on the recombinant DNA technology market, request a sample here

How will the recombinant DNA technology market drivers and restraints affect the recombinant DNA technology market dynamics? What forces will shape the recombinant DNA technology industry going forward?

The recombinant DNA technology market major growth driver - rising prevalence of chronic diseases to drive market growth. For further insights on the recombinant DNA technology market, request a sample here

What is the forecast market size or the forecast market value of the recombinant DNA technology market ?

The recombinant DNA technology market size has grown strongly in recent years. It will grow from $816.9 billion in 2023 to $882.04 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to healthcare demands, biopharmaceutical industry growth, rising investments in r&d, emergence of personalized medicine. The recombinant DNA technology market size is expected to see strong growth in the next few years. It will grow to $1214.85 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising chronic diseases, emerging biotech startups, increasing funding in biotech, globalization of biotech markets, consumer acceptance and education. Major trends in the forecast period include scientific advancements, gene editing advancements, cell and gene therapies, development of rna therapeutics, therapeutic applications in rare diseases, ai and data integration. For further insights on the recombinant DNA technology market, request a sample here

How is the recombinant DNA technology market segmented?

The recombinant DNA technology market is segmentedThe recombinant DNA technology market covered in this report is segmented –
1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing
2) By Component Type: Expression System, Cloning Vector
3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types
4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use TypesFor further insights on the recombinant DNA technology market, request a sample here

Which region has the largest share of the recombinant DNA technology market? What are the other regions covered in the report?

North America was the largest region in the recombinant DNA technology market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant DNA technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the recombinant DNA technology market, request a sample here.

Who are the major players in the recombinant DNA technology market?

Major companies operating in the recombinant DNA technology market report are Profacgen BioTech Corp., Amgen Inc., Novartis International AG, GenScript Biotech Corporation, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co. Inc., Biogen Inc., GlaxoSmithKline plc, New England Biolabs Inc., Bayer CropScience, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Gilead Sciences Inc., Moderna Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics AG, Editas Medicine Inc., bluebird bio Inc., Illumina Inc., Qiagen N.V., Lonza Group AG, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Becton Dickinson and Company, Sartorius AG, Abcam plc, Horizon Discovery Group plc, Integrated DNA Technologies Inc., Twist Bioscience Corporation, Synthego Corporation, Codex DNA Inc., InvivoGen, Eurofins Scientific SE, Sarepta Therapeutics Inc., Sangamo Therapeutics Inc. For further insights on the recombinant DNA technology market, request a sample here.

What are the key trends in the recombinant DNA technology market?

Major trend in the recombinant DNA technology market - technological advancements driving innovation in recombinant DNA technology market. For further insights on the recombinant DNA technology market, request a sample here.

What are the major opportunities in the recombinant DNA technology market? What are the strategies for the recombinant DNA technology market?

For detailed insights on the major opportunities and strategies in the recombinant DNA technology market, request a sample here.

How does the recombinant DNA technology market relate to the overall economy and other similar markets?

For detailed insights on recombinant DNA technology market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the recombinant DNA technology industry?

For detailed insights on the mergers and acquisitions in the recombinant DNA technology industry, request a sample here.

What are the key dynamics influencing the recombinant DNA technology market growth? SWOT analysis of the recombinant DNA technology market.

For detailed insights on the key dynamics influencing the recombinant DNA technology market growth and SWOT analysis of the recombinant DNA technology industry, request a sample here.